The challenges of determining noninferiority margins: a case study of noninferiority randomized controlled trials of novel oral anticoagulants

Grace Wangge, Kit C. B. Roes, Anthonius de Boer, Arno W. Hoes, Mirjam J. Knol

Canadian Medical Association Journal · 2012 · 32 citations · 17 references

DOIFull text

Open access

Concepts

Abstract

A randomized controlled trial (RCT) can have either a superiority design or a noninferiority design. A superiority design aims to show that a new drug is better than placebo or an active comparator, whereas a noninferiority design aims to show that a new drug is not worse than its comparator, which

References

17